QT
KURA icon

Quantbot Technologies’s Kura Oncology KURA Stock Holding History

Quantbot Technologies’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-701
Closed -$5.7K – 2090
2026
Q1 		$5.7K Buy
+701
New +$6.02K ﹤0.01% 1573
2024
Q3 		– Sell
-14
Closed -$288 – 1659
2024
Q2 		$288 Sell
14
-3,486
-100% -$71.7K ﹤0.01% 1368
2024
Q1 		$74.7K Buy
+3,500
New +$68K ﹤0.01% 1265
2021
Q4 		– Sell
-6,700
Closed -$125K – 1719
2021
Q3 		$125K Sell
6,700
-4,300
-39% -$81K 0.01% 912
2021
Q2 		$229K Buy
11,000
+6,400
+139% +$159K 0.02% 714
2021
Q1 		$130K Buy
+4,600
New +$146K 0.01% 819
2019
Q4 		– Sell
-2,249
Closed -$34K – 1431
2019
Q3 		$34K Buy
+2,249
New +$40K ﹤0.01% 1049

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Quantbot Technologies's KURA Position: Q2 2026 in Review

Quantbot Technologies sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 701 shares — an estimated $5.7K sold.

Quantbot Technologies first reported a position in KURA in Q3 2019 and held it in 7 quarters. The position peaked at $229K in Q2 2021. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Quantbot Technologies reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 701 Kura Oncology shares in Q2 2026, an estimated $5.7K.
  • Quantbot Technologies first reported a position in Kura Oncology in Q3 2019 and held it in 7 quarters.
  • Quantbot Technologies's Kura Oncology position peaked at $229K in Q2 2021.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.